Journal article
An estimate of the cost of conducting phase II trials in lung cancer
Abstract
OBJECTIVE: Although it is commonly assumed that clinical trials are more costly than standard therapy, there have been no previous studies of the cost of conducting phase II trials in lung cancer. We retrospectively analyzed two National Cancer Institute of Canada phase II trials in previously untreated small cell lung cancer (SCLC) to determine the costs of conducting the trials in a cancer treatment centre. Both studies were clinical trials …
Authors
Evans WK; Dahrouge S; Stapleton J; Quinn C; Pollock D; Waterfield B; Lister D; Hansel F; Smith A
Journal
Lung Cancer, Vol. 28, No. 2, pp. 85–95
Publisher
Elsevier
Publication Date
May 2000
DOI
10.1016/s0169-5002(99)00132-4
ISSN
0169-5002